BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 30, 2025
Home » Authors » Robert Kimball

Articles by Robert Kimball

MDD's Neurology Extra

Feb. 3, 2014
By Robert Kimball

MDD's Neurology Extra

Jan. 27, 2014
By Robert Kimball

MDD's Neurology Extra

Jan. 13, 2014
By Robert Kimball

MDD's Neurology Extra

Jan. 6, 2014
By Robert Kimball

Keeping you up to date on recent developments in neurology

Dec. 23, 2013
By Robert Kimball

MDD's Neurology Extra

Dec. 16, 2013
By Robert Kimball

MDD's Neurology Extra

Dec. 9, 2013
By Robert Kimball

Sundays with Peyton now not a pain in the neck

Nov. 20, 2013
By Robert Kimball
It is fall here in the U.S. and, for many Americans, that time of year brings cooler weather and football. Apologies to our non-U.S. readers, I realize that you have ownership on “real” football, and our version is secular at best. But, hey, football is ours and we sure do like it. It is during this time I like to reflect and “brag” that I have something in common with arguably one of the greatest quarterbacks to play the game – certainly in the modern era. You see, Peyton Manning and I share a common bond. No, my father...
Read More

MDD's 3Q13 Report: Companies agree to run the gambit from robotics to RFID technology

Oct. 8, 2013
By Robert Kimball

Deals roundup: Community Health Systems to acquire HMA for $7.6B

July 31, 2013
By Robert Kimball
Previous 1 2 … 5 6 7 8 9 10 11 12 13 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 29, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 29, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • 3d rendering of bispecific antibodies

    Pfizer bets $6B+ on 3Sbio’s bispecific PD-1/VEGF antibody

    BioWorld
    Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific...
  • KT-621: a first-in-class STAT6 degrader for Th2-driven diseases

    BioWorld Science
    STAT6 plays a central role in regulating Th2-driven immune responses. Recent studies have identified gain-of-function mutations in the STAT6 gene that are...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing